Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Status:
RECRUITING
Trial end date:
2033-08-31
Target enrollment:
Participant gender:
Summary
Randomized, placebo-controlled, double-blinded, parallel group clinical trial to investigate if 6 months of oral lithium tablets (S-lithium 0,5-1,0 mmol/l) will prevent cognitive decline after brain radiotherapy in pediatric brain tumor survivors.
Primary outcome measure is Processing Speed Index (PSI) 2 years after start of study treatment.